Standout Papers

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 2021 2026 2022 2024153
  1. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls (2021)
    Basil T. Darras, Riccardo Masson et al. New England Journal of Medicine

Immediate Impact

28 standout
Sub-graph 1 of 13

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions
2024 Standout
2 intermediate papers

Works of D. Vlodavets being referenced

CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
2019

Author Peers

Author Last Decade Papers Cites
D. Vlodavets 241 247 154 44 422
John F. Brandsema 183 95 71 30 423
Simon Witzel 169 236 112 22 375
Cheul-Hong Kim 81 97 121 36 429
Yoshihiro Momota 95 81 123 56 425
Robert Carlier 225 141 78 28 444
Radboud W. Koot 84 83 75 32 398
Jamie E. Anderson 85 66 147 31 470
Hiroko Hirano 83 74 146 68 479
Joaquin Camara‐Quintana 62 74 187 38 451
Jan Lehovsky 142 55 252 23 452

All Works

Loading papers...

Rankless by CCL
2026